相关实验视频
Updated: Sep 9, 2025

09:17
Using Retinal Imaging to Study Dementia
Published on: November 6, 2017
21.8K
新诊断患有痴呆症的老年人中C反应蛋白预测功能衰退:一项为期5年的随访研究
Miguel Germán Borda1, Tommy Cederholm2, Salomón Salazar-Londoño3
1Department of Neurology, Clínica Universidad de Navarra, Pamplona, Spain; Centre for Age-Related Medicine (SESAM), Stavanger University Hospital, Stavanger, Norway; Centro de Investigación en Ciencias de la Salud (CICSA), FCS, Universidad Anáhuac México Campus Norte, Huixquilucan Edo. de México, Mexico.
Revista espanola de geriatria y gerontologia
|August 28, 2025
概括
在痴呆症患者中,C反应蛋白 (CRP) 与功能衰退的增加有关. 这种炎症标记预测新诊断的个体的能力会恶化,但不会减肥或死亡.
科学领域:
- 神经科学
- 老年学
- 免疫学
背景情况:
- 痴呆症的患病率正在上升,
- C反应蛋白 (CRP) 是一种易于获得的炎症标志物.
- 早期识别痴呆症进展标志物对于患者的结果至关重要.
研究的目的:
- 研究C反应蛋白 (CRP) 作为减肥,认知衰退,功能衰退和死亡率的预测因素.
- 评估新诊断患有痴呆症的老年人CRP的预后价值.
主要方法:
- 使用了DemVest纵向队列研究的数据.
- 包括因阿尔茨海默病 (AD) 或莱维体痴呆症 (LBD) 而导致轻度痴呆症的参与者.
- 使用回归和混合模型测量诊断时的CRP水平,并分析5年内的功能衰退,体重,BMI,认知衰退和死亡率.
主要成果:
- 在5年随访期间,CRP水平升高与功能衰退有显著的相关性.
- 在CRP水平和体重,BMI,认知能力下降 (MMSE) 或死亡率之间没有发现统计学意义上的关联.
- 这项研究包括158名参与者 (平均年龄为75. 2岁),其中60. 8%被诊断为阿尔茨海默氏症,39. 2%为LBD.
结论:
- 较高的C反应蛋白 (CRP) 水平与新诊断的痴呆症患者的功能衰退有关.
- 在痴呆症患者中,CRP可作为功能恶化的预后指标.
更多相关视频
相关概念视频
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
213
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
213
Alzheimer's Disease: Overview
666
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
666
Cognitive Development During Adulthood
255
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
255
Alzheimer's Disease: Treatment
260
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
260
Dementia
165
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
165

